---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-024811"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:19:36.244490+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Foghorn Therapeutics furnishes investor presentation; no specific material updates disclosed in exhibit

## Summary
- Investor presentation title: 'Unique biology, Precision therapeutics, Broad impact' — no additional content provided.
- No financial results, pipeline updates, or guidance changes are included in this filing.
- The filing does not contain any material new information beyond the existence of the presentation.

## SEC filing metadata
- accession: 0001628280-24-024811
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828024024811/0001628280-24-024811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828024024811/fhtx-20240523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-024811
- JSON: https://secwatch.observer/filing/0001628280-24-024811.json
- Plain text: https://secwatch.observer/filing/0001628280-24-024811.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.